Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo

Laboratory Investigation

Volumn 79, Issue 12, 1999, Pages 1469-1477

  Sawaoka, Hitoshi ^a   Tsuji, Shingo ^a   Tsujii, Masahiko ^a   Gunawan, Edhi S ^a   Sasaki, Yutaka ^a   Kawano, Sunao ^b   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN SYNTHASE INHIBITOR;

ANGIOGENESIS; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GROWTH INHIBITION; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CELL DIVISION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; INDOMETHACIN; ISOENZYMES; LYMPHOKINES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONAMIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033391630     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Albelda SM, Muller WA, Buck C, and Newman PJ (1991). Molecular and cellular properties of PECAM-1 (endoCAM/ CD31): A novel vascular cell-cell adhesion molecule. J Cell Bio 114:1059-1068.
2. Bossi P, Viale G, Lee AKC, Alfano R, Coggi G, and Bosari S (1995). Angiogenesis in colorectal tumors: Microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res 55:5049-5053.
3. Brattain MG, Fine WD, Khaled FM, Thompson J, and Brattain, DE (1981). Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res 41:1751-1756.
4. Brune K, Dietzel K, Nurnberg B, and Schneider HT (1987). Recent insight into the mechanism of gastrointestinal tract ulceration. Eur J Rheumatol Inflamm 9:8-14.
5. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, and DuBois RN (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188.
6. Folkman J (1990). What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6.
7. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, and Otomo S (1994). NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59.
8. Futaki N, Yoshikawa K, Hamasaka Y, Arai I, Higuchi S, Iizuka H, and Otomo S (1993). NS-398, a novel nonsteroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmac 24:105-110.
9. Gavrieli Y, Sherman Y, and Ben-Sasson SA (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
10. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, and Siebert K (1995). Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 305:479-484.
11. Gold R (1994). Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71:219-225.
12. Houchens DP, Ovejera AA, and Barker AD (1978). The treatment of human tumors in athymic (nude) mice. In: Houchens DP and Ovejera AA editors. Proceedings of the symposium on the use of athymic (nude) mice in cancer research. New York: Gustav Fischer, 267-280.
13. Koolwijk P, van Erck MG, de Vree WJ, Vermeer MA, Weich, H. A., Hanemaaijer, R., and van Hinsbergh, V. W (1996). Cooperative effect of TGF-α, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 132:1177-1188.
14. Motoyama T, Hojo H, and Watanabe H (1986). Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36:65-83.
15. Nugent KP, Farmer KC, Spiegelman AD, Williams CB, and Phillips RK (1993). Randomized double blind placebo controlled clinical trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in familial adenomatous polyposis. Br J Surg 80:1618-1619.
16. Ristimäki A, Honkanen N, Jänkälä H, Sipponen P, and Härkönen M (1997). Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57:1276-1280.
17. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, and Shapiro S (1991). A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83:355-358.
18. Smalley W and DuBois, R. N (1997). Colorectal cancer and nonsteroidal antiinflammatory drugs. Adv Pharmacol 39:1-20.
19. Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M. (1998b) Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 274:G1061-G1067.
20. Sawaoka H, Kawano S., Tsuji S, Tsujii M, Murata H, Hori M. (1998a) Effects of NSAID on proliferation of gastric cancer cells in vitro. Possible implication of cyclooxygenase-2 in gastric cancer development. J Clinical Gastroenterology 27: S48-S53.
21. Takei Y, Marzi I, Kauffman FC, Currin RT, Lemasters JJ, and Thurman RG (1990). Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine. Transplantation 50:14-20.
22. Thun M, Namboodiri M, Calle EE, Flanders WD, and Heath CW (1993). Aspirin use and risk of cancer. Cancer Res 53:1322-1327.
23. Thun MJ, Namboodiri MM, and Heath CWJ (1991). Aspirin use and reduced risk of fatal colon cancer. New Engl J Med 325:1593-1596.
24. Tsujii M and DuBois RN (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83:493-501.
25. Tsuji S, Kawano S, Sawaoka H, Takei Y, Kobayashi I, Nagano K, Fusamoto H, and Kamada T (1996). Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostagland Leukotri Ess Fatty Acids 55:179-183.
26. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, and DuBois RN (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716.
27. Warren RS, Yuan H, Matli MR, Gillett NA, and Ferrara N (1995). Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95:1789-1797.
28. Weidner N, Semple JP, Welch WR, and Folkman J (1991). Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. New Engl J Med 324:1-8.
29. Xie Y and Muller WA (1993). Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Proc Natl Acad Sci USA 90:5569-5573.